{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T22:51:18Z","timestamp":1789858278724,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Cells, Molecules, and Diseases"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.bcmd.2015.09.006","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T18:59:00Z","timestamp":1443553140000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Serum YKL-40 in young patients with \u03b2-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications"],"prefix":"10.1016","volume":"56","author":[{"given":"Mohamed Abo","family":"El-Asrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8713-0657","authenticated-orcid":false,"given":"Nancy Samir","family":"Elbarbary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Abdel Rahman","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohamed","family":"Elshenity","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcmd.2015.09.006_bb0005","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2459\/JCM.0b013e3282f20847","article-title":"Society for the study of thalassemia and hemoglobinopathies (SoSTE)","volume":"9","author":"Cogliandro","year":"2008","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0010","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/ehm.11.29","article-title":"Complications of thalassemia major and their treatment","volume":"4","author":"Borgna-Pignatti","year":"2011","journal-title":"Expert. Rev. Hematol."},{"issue":"Suppl. 1","key":"10.1016\/j.bcmd.2015.09.006_bb0015","first-page":"118","article-title":"Prevalence of anti HCV infection in patients with beta-thalassemia in Isfahan-Iran","volume":"3","author":"Ataei","year":"2012","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0020","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1111\/j.1537-2995.2009.02252.x","article-title":"Distribution of hepatitis C virus genotype in Iranian multiply transfused patients with thalassemia","volume":"49","author":"Alavian","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0025","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.3748\/wjg.v13.i17.2436","article-title":"Epidemiology of hepatitis C virus infection","volume":"13","author":"Alter","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0030","article-title":"Serum YKL-40 levels and chitotriosidase activity in patients with beta-thalassemia major","volume":"965971","author":"Musumeci","year":"2014","journal-title":"Dis. Markers"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/hep.21173","article-title":"Liver disease in Egypt: hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors","volume":"43","author":"Strickland","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0040","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJM200008033430503","article-title":"Hepatic iron concentration and total body iron stores in thalassemia major","volume":"343","author":"Angelucci","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0045","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/hepr.12088","article-title":"Transient elastography in hepatitis C virus-infected patients with beta-thalassemia for assessment of fibrosis","volume":"43","author":"Poustchi","year":"2013","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0050","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0055","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/ajh.21752","article-title":"Transient elastography in the assessmentof liver fibrosis in adult thalassemia patients","volume":"85","author":"Fraquelli","year":"2010","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0060","first-page":"605","article-title":"Fibroscan (transient elastography) for the measurement of liver fibrosis","volume":"8","author":"Afdhal","year":"2012","journal-title":"Gastroenterol. Hepatol. (NY)"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0065","article-title":"Studies on serum YKL-40 as a biomarker in diseases with inflammation, tissue remodelling, fibroses and cancer","volume":"172-209","author":"Johansen","year":"2006","journal-title":"Dan. Med. J."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0070","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1006\/bbrc.2001.5253","article-title":"YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes","volume":"285","author":"De Ceuninck","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0075","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1042\/bj20040099","article-title":"The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-\u03b1","volume":"380","author":"Ling","year":"2004","journal-title":"Biochem. J."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0080","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1475-2840-8-61","article-title":"YKL-40 \u2014 an emerging biomarker in cardiovascular disease and diabetes","volume":"8","author":"Rathcke","year":"2009","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0085","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/joca.2000.0377","article-title":"Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology","volume":"9","author":"Volck","year":"2001","journal-title":"Osteoarthr. Cartil."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0090","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1161\/01.ATV.19.3.687","article-title":"Strong induction of members of the chitinase family of proteins in atherosclerosis: chitotriosidase and human cartilage gp-39 expressed in lesion macrophages","volume":"19","author":"Boot","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0095","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1056\/NEJMoa073600","article-title":"A chitinase-like protein in the lung and circulation of patients with severe asthma","volume":"357","author":"Chupp","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0100","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/BF00870306","article-title":"Liver fibrosis","volume":"21","author":"Pinzani","year":"2006","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0105","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.70.2.163","article-title":"Functional heterogeneity in liver and lung macrophages","volume":"70","author":"Laskin","year":"2001","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0110","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3109\/00365529709025104","article-title":"Plasma YKL-40: a new potential marker of fibrosis in patients with alcoholic cirrhosis?","volume":"32","author":"Johansen","year":"1997","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0115","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/hep.21117","article-title":"Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis","volume":"43","author":"Kamal","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0120","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.3109\/00365521.2011.613949","article-title":"YKL-40 and transient elastography, a powerful team to assess hepatic fibrosis","volume":"13","author":"Rath","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0125","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.actatropica.2005.07.009","article-title":"Determination of serum levels of YKL-40 and hyaluronic acid in patients with hepatic fibrosis due to schistosomiasis japonica and appraisal of their clinical value","volume":"96","author":"Zheng","year":"2005","journal-title":"Acta Trop."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0130","series-title":"Hematology: Basic Principles and Practice","first-page":"535","article-title":"Thalassemia syndromes","author":"PJV","year":"2008"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0135","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2165\/00003495-200767150-00007","article-title":"Deferasirox: a review of its use in the management of transfusional chronic iron overload","volume":"67","author":"Yang","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0140","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s12098-010-0030-4","article-title":"Deferasirox: oral, once daily iron chelator \u2014 an expert opinion","volume":"77","author":"Agarwal","year":"2010","journal-title":"Indian J. Pediatr."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0145","doi-asserted-by":"crossref","first-page":"72","DOI":"10.5045\/br.2014.49.1.72","article-title":"Efficacy and safety of combined oral iron chelation therapy with deferasirox and deferiprone in a patient with beta-thalassemia major and persistent iron overload","volume":"49","author":"Alavi","year":"2014","journal-title":"Blood Res."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0150","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1524-4733.2007.00213.x","article-title":"Medication compliance and persistence: terminology and definitions","volume":"11","author":"Cramer","year":"2008","journal-title":"Value Health"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0155","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1542\/peds.2007-0730","article-title":"Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease","volume":"121","author":"Pashankar","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0160","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1182\/blood-2010-11-319152","article-title":"Risk factors and mortality associated with an elevated tricuspid regurgitant jet velocity measured by Doppler-echocardiography in thalassemia: a Thalassemia Clinical Research Network report","volume":"118","author":"Morris","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0165","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1378\/chest.127.5.1523","article-title":"Thalassemia heart disease: a comparative evaluation of thalassemia major and thalassemia intermedia","volume":"127","author":"Aessopos","year":"2005","journal-title":"Chest"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0170","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29","author":"Sandrin","year":"2003","journal-title":"Ultrasound Med. Biol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0175","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3748\/wjg.v19.i1.49","article-title":"Performance of liver stiffness measurements by transient elastography in chronic hepatitis","volume":"19","author":"Ferraioli","year":"2013","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.bcmd.2015.09.006_bb0180","first-page":"1012","article-title":"Hepatic steatosis and necro-inflammatory activity overestimate liver stiffness by transient elastography in staging liver fibrosis in chronic hepatitis C","volume":"1","author":"Rinaldi","year":"2014","journal-title":"J. Hepat. Res."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0185","doi-asserted-by":"crossref","first-page":"e15426","DOI":"10.5812\/hepatmon.15426","article-title":"Evaluating liver fibrosis by transient elastometry in patients with HIV\u2013HCV coinfection and monoinfection","volume":"14","author":"Brescini","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0190","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1182\/blood-2004-10-3982","article-title":"MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients","volume":"106","author":"Wood","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0195","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/MOH.0b013e3280d2b76b","article-title":"Magnetic resonance imaging measurement of iron overload","volume":"14","author":"Wood","year":"2007","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0200","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload","volume":"22","author":"Anderson","year":"2001","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0205","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-0609.2005.00587.x","article-title":"Evaluation of the efficacy of oral deferiprone in 3 beta-thalassemia major by multislice multiecho T2*","volume":"76","author":"Pepe","year":"2006","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0210","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1080\/03630260601057088","article-title":"Rapid detection of beta thalassemia alleles in Egypt using naturally or amplified created restriction sites and direct sequencing: a step in disease control","volume":"31","author":"Hussein","year":"2007","journal-title":"Hemoglobin"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0215","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejmhg.2012.03.006","article-title":"Thalassemia intermedia: an overview","volume":"13","author":"Shawky","year":"2012","journal-title":"Egypt J. Med. Hum. Genet."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0220","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1182\/blood-2002-06-1867","article-title":"Role of deferiprone in chelation therapy for transfusional iron overload","volume":"102","author":"Hoffbrand","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0225","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1182\/blood-2006-02-002394","article-title":"Oral chelators deferasirox and deferiprone for transfusional iron overload in thalassemia major: new data, new questions","volume":"107","author":"Neufeld","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0230","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2141.2009.07970.x","article-title":"Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major","volume":"148","author":"Farmaki","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1532-429X-15-1","article-title":"Cardiac and hepatic iron and ejection fraction in thalassemia major: multicentre prospective comparison of combined deferiprone and deferoxamine therapy against deferiprone or deferoxamine monotherapy","volume":"15","author":"Pepe","year":"2013","journal-title":"J. Cardiovasc. Magn. Reson."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0240","first-page":"610","article-title":"Seropositivity of hepatitis C, hepatitis B and HIV in chronically transfused \u03b2-thalassaemia major patients","volume":"22","author":"Ansari","year":"2012","journal-title":"J. Coll. Physicians Surg. Pak."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0245","first-page":"56","article-title":"Treatment outcome of HCV infected paediatric patients and young adults at Karachi, Pakistan","volume":"24","author":"Aziz","year":"2012","journal-title":"J. Ayub Med. Coll. Abbottabad"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0250","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1600-0609.2007.01011.x","article-title":"Non-invasive assessment of liver fibrosis by transient elastography in post transfusional iron overload","volume":"80","author":"Mirault","year":"2008","journal-title":"Eu.r J. Haematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0255","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1365-2141.2009.07996.x","article-title":"Noninvasive assessment of liver fibrosis in thalassaemia major patients by transient elastography (TE) \u2014 lack of interference by iron deposition","volume":"148","author":"Di Marco","year":"2010","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0260","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ajg.2012.06.006","article-title":"Predictive accuracy of serum hyaluronic acid as a non-invasive marker of fibrosis in a cohort of multi-transfused Egyptian children with \u03b2-thalassaemia major","volume":"13","author":"El-Shabrawi","year":"2012","journal-title":"Arab J. Gastroenterol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0265","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ejh.12086","article-title":"Natural history of hepatitis C in thalassemia major: a long-term prospective study","volume":"90","author":"Lai","year":"2013","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0270","first-page":"1611","article-title":"Relationship between elevated liver enzyme with iron overload and viral hepatitis in thalassemia major patients in Northern Iran","volume":"29","author":"Ameli","year":"2008","journal-title":"Saudi Med. J."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0275","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S0140-6736(99)06527-7","article-title":"The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt","volume":"355","author":"Frank","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0280","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/j.jhep.2006.12.010","article-title":"Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C","volume":"46","author":"Esmat","year":"2007","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0285","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0168-8278(03)00184-3","article-title":"Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease","volume":"39","author":"Nojgaard","year":"2003","journal-title":"J. Hepatol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0290","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1053\/jhep.2003.50376","article-title":"Novel differential gene expression in human cirrhosis detected by suppression subtractive hybridization","volume":"38","author":"Shackel","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0295","doi-asserted-by":"crossref","first-page":"476","DOI":"10.3748\/wjg.v11.i4.476","article-title":"Noninvasive estimation of liver fibrosis and response to interferon therapy by a serum fibrogenesis marker, YKL-40, in patients with HCV associated liver disease","volume":"11","author":"Saitou","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"9","key":"10.1016\/j.bcmd.2015.09.006_bb0300","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00042737-200012090-00004","article-title":"Chondrex (YKL-40), a potential new serum fibrosis marker in patients with alcoholic liver disease","volume":"12","author":"Tran","year":"2000","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0305","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1365-2893.2008.00992.x","article-title":"Serum levels of YKL-40 and hyaluronic acid as noninvasive markers of liver fibrosis in haemodialysis patients with chronic hepatitis C virus infection","volume":"15","author":"Schiavon","year":"2008","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0310","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2008.10.034","article-title":"Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis","volume":"7","author":"Fontana","year":"2009","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0315","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1136\/gut.2010.207423","article-title":"Serum fibrosis markers are associated with liver disease progression in non-responder patients with chronic hepatitis C","volume":"59","author":"Fontana","year":"2010","journal-title":"Gut"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0320","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1440-1746.2012.07270.x","article-title":"YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease","volume":"28","author":"Eurich","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0325","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3324\/haematol.2011.047852","article-title":"Elevated liver iron concentration is a marker of increased morbidity in patients with \u03b2 thalassemia intermedia","volume":"96","author":"Musallam","year":"2011","journal-title":"Haematologica"},{"issue":"Suppl 5","key":"10.1016\/j.bcmd.2015.09.006_bb0330","doi-asserted-by":"crossref","first-page":"v8","DOI":"10.1093\/ndt\/gfg1034","article-title":"Haem, haem oxygenase and ferritin in vascular endothelial cell injury","volume":"18","author":"Balla","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0335","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5114\/aoms.2010.13514","article-title":"Left ventricular diastolic abnormalities and the impact of hepatitis C virus infection in multitransfused Egyptian children","volume":"6","author":"El-Waseef","year":"2010","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0340","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1475-2840-10-54","article-title":"YKL-40 levels are independently associated with albuminuria in type 2 diabetes","volume":"10","author":"R\u00f8ndbjerg","year":"2011","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0345","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.imbio.2011.04.007","article-title":"Can YKL-40 be a new inflammatory biomarker in cardiovascular disease?","volume":"217","author":"Kastrup","year":"2012","journal-title":"Immunobiology"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0350","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/MCA.0b013e328241d991","article-title":"Serum YKL-40 levels in patients with coronary artery disease","volume":"18","author":"Kucur","year":"2007","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14017430802220567","article-title":"YKL-40 a new biomarker in patients with acute coronary syndrome or stable coronary artery disease","volume":"42","author":"Wang","year":"2008","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0360","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1093\/eurheartj\/ehp049","article-title":"High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease","volume":"30","author":"Kastrup","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0365","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/europace\/eup103","article-title":"Plasma YKL-40, a new biomarker for atrial fibrillation?","volume":"11","author":"Henningsen","year":"2009","journal-title":"Europace"},{"key":"10.1016\/j.bcmd.2015.09.006_bb0370","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/ana.22220","article-title":"Elevated plasma YKL-40 levels and ischemic stroke in the general population","volume":"68","author":"Kjaergaard","year":"2010","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bcmd.2015.09.006_bb0375","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cardfail.2010.05.029","article-title":"Serum YKL-40 predicts adverse clinical outcomes in patients with chronic heart failure","volume":"16","author":"Bilim","year":"2010","journal-title":"J. Card. Fail."}],"container-title":["Blood Cells, Molecules, and Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615001722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1079979615001722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T12:31:20Z","timestamp":1761049880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1079979615001722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":75,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S1079979615001722"],"URL":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.09.006","relation":{},"ISSN":["1079-9796"],"issn-type":[{"value":"1079-9796","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum YKL-40 in young patients with \u03b2-thalassemia major: Relation to hepatitis C virus infection, liver stiffness by transient elastography and cardiovascular complications","name":"articletitle","label":"Article Title"},{"value":"Blood Cells, Molecules, and Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcmd.2015.09.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}